ICMR recommends hydroxychloroquine for high-risk population

Question: Consider the following statements:
(1) Hydroxychloroquine (HCQ) is a medication used for the prevention and treatment of certain types of malaria.
(2) ICMR is the apex body in India for the formulation, coordination and promotion of biomedical research.
Choose the correct:
(a) Only(1)
(b) Only(2)
(c) Both (1) and (2)
(d) None of the above
Answer:(c)
Related facts:

  • The national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive medication for high-risk population.
  • ICMR directed that the hydroxy-chloroquine should be given to high-risk population asymptomatic healthcare workers.
  • The medication can be used to treat the suspected and confirmed cases of COVID-19 and asymptomatic household contacts of laboratory-confirmed cases.
  • The Drug Controller General of India (DGCI) approved the usage of hydroxychloroquine for restricted use in emergency situations.

Hydroxychloroquine (HCQ):

  • It is a medication used for the prevention and treatment of certain types of malaria.
  • Specifically it is used for chloroquine-sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutaneatarda.

Indian Council of Medical Research (ICMR):

  • ICMR is the apex body in India forthe formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world.
  • It is located in New Delhi.

Links:
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-covid-task-force-recommends-hydroxychloroquine-for-high-risk-patients-with-strict-riders/articleshow/74774540.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

https://www.icmr.nic.in/content/about-us